Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06007794 | NOT YET RECRUITING | Cancer

Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)
Sponsor:

Civil Hospices of Lyon

Brief Summary:

Therapeutic advances in oncology have transformed the prognosis of cancer patients, placing a significant number of them either in a context of recovery or in prolonged remission close to a chronic disease. Thus, the reconquest of a life after cancer becomes possible but raises many challenges for the patient, his entourage, the medical profession and our society. One of the major challenges is the detection and management of treatment side effects for all patients. In addition to the standard organic assessment (glycaemia, creatinine, liver test, blood count), we are mainly interested in muscle deconditioning and cognitive impairment, which are particularly disturbed in these populations. After the evaluation day, patients are referred to the most appropriate structures (Adapted physical activity, sports for health, and rehabilitation at Henry Gabriel Hospital). JUMP research is part of axis 2 of the 2021-2030 cancer plan: "Limiting sequelae and improving quality of life", through sheets 1 (research) / 6 (access and quality) / 7 (prevention). This leads to the concrete implementation on the territory of adapted care channels in the city: medical structure, physiotherapy, Adapted Physical Activity (APA) structures, associative structures; which makes it possible to develop and strengthen the city-hospital link. Finally, it allows the patient to take ownership and get involved in the project, allowing in the future to make them truly active in they care and to advise and motivate their peers. This non-interventional research is classified as "research involving human subjects", class 3 . The objective of this research is to evaluate the impact of cancer on the musculoskeletal system and to test ultrasound as a clinical examination for the detection of sarcopenia in this population.

Condition or disease

Cancer

Post-cancer

Hematology

Intervention/treatment

JUMP group

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 55 participants
Masking : NONE
Primary Purpose : PREVENTION
Official Title : Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)
Actual Study Start Date : 2025-01-01
Estimated Primary Completion Date : 2029-01-01
Estimated Study Completion Date : 2029-01-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 74 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Age : 18 to 74 years
  • * localization of the primitive: breast, lung, melanoma, testicle, bladder, kidney, ovary, colon and pancreas, hemopathy
  • * patient who benefited from the post-cancer assessment day
Exclusion Criteria
  • * Active cancer (relapse or new cancer)
  • * Pregnant or breastfeeding women
  • * Major cognitive impairment making comprehension and exercise difficult
  • * Amputation of both lower limbs (for ultrasound)
  • * Difficulty understanding oral and written French
  • * Adults under legal protection (guardianship, curatorship or safeguard of justice)
Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)

Location Details

NCT06007794

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

France,

Lyon Sud Hospital, rheumatology

Pierre-Bénite, France, 69495